Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli.
A greater knowledge of the neurochemical changes occurring during pain states will undoubtedly aid in the discovery of effective pain pharmacotherapies. This study highlights the acute effects of inflammatory agents on neurochemical changes in the rostral ventromedial medulla (RVM), a supraspinal site involved in the processing of painful stimuli. Consistent with previous reports, a peripheral injection of 0.1 mg prostaglandin E(2) (PGE(2)) into the intraplantar area of the rat paw produced thermal hypersensitivity that peaked 10 min after administration. In vivo microdialysis studies in the same animals revealed that this behavioral response correlated with a greater than 2-fold increase (230%) in extracellular serotonin (5-HT) levels in the RVM. In contrast, levels of other neurotransmitters measured, including norepinephrine and dopamine, were not altered in animals receiving this inflammatory agent. Similar to PGE(2), an intraplantar injection of capsaicin (0.1 mg) produced a robust thermal hypersensitivity that was paralleled by a 3-fold increase in levels of 5-HT in the RVM. The next series of experiments showed that acute administration of the opioid analgesic, morphine (5.6 mg/kg; IP), attenuated PGE(2)-induced thermal hypersensitivity and reversed the increase in extracellular 5-HT observed in the RVM. Taken together, these findings extend previous reports of central neurochemical changes during inflammatory pain conditions and show that the combination of behavioral endpoints with microdialysis can yield important insights into the neurochemical environment of the pain circuitry.
Smith
Valerie A
VA
Discovery Neuroscience, Wyeth Research, Princeton, NJ 08543-8000, USA.
Beyer
Chad E
CE
Brandt
Michael R
MR
D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal; D015306:Biogenic Monoamines / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology*; D002211:Capsaicin / Q000009:adverse effects; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D015232:Dinoprostone / Q000009:adverse effects; D004347:Drug Interactions; D004563:Electrochemistry / Q000379:methods; D006358:Hot Temperature / Q000009:adverse effects; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects / Q000378:metabolism*; D017551:Microdialysis / Q000379:methods; D009020:Morphine / Q000008:administration & dosage; D009294:Narcotics / Q000008:administration & dosage; D010146:Pain / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism* / Q000473:pathology; D010147:Pain Measurement / Q000187:drug effects / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects
D015306:Biogenic Monoamines; D009294:Narcotics; D009020:Morphine; D015232:Dinoprostone; D002211:Capsaicin